Pulmonx CorpNASDAQ:LUNG
- LAST PRICE7.2800
- TODAY'S CHANGE (%)-0.0200 (-0.2740%)
- Bid / Lots2.9300/ 2
- Ask / Lots7.5900/ 1
- Open / Previous Close7.3200 / 7.3000
- Day Range
- 52 Week Range
- Volume388,074
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LUNG |
|---|---|---|
| 09:32 ET | 1011 | 7.32 |
| 09:41 ET | 300 | 7.36 |
| 09:56 ET | 300 | 7.45 |
| 10:01 ET | 392 | 7.44 |
| 10:06 ET | 200 | 7.46 |
| 10:14 ET | 700 | 7.48 |
| 10:17 ET | 644 | 7.48 |
| 10:24 ET | 200 | 7.46 |
| 10:26 ET | 311 | 7.45 |
| 10:33 ET | 100 | 7.45 |
| 10:35 ET | 400 | 7.46 |
| 10:46 ET | 800 | 7.48 |
| 10:51 ET | 200 | 7.495 |
| 10:53 ET | 100 | 7.48 |
| 10:55 ET | 200 | 7.46 |
| 11:02 ET | 100 | 7.48 |
| 11:04 ET | 200 | 7.49 |
| 11:09 ET | 656 | 7.455 |
| 11:15 ET | 500 | 7.43 |
| 11:22 ET | 100 | 7.42 |
| 11:24 ET | 200 | 7.4 |
| 11:27 ET | 200 | 7.42 |
| 11:31 ET | 448 | 7.39 |
| 11:36 ET | 300 | 7.39 |
| 11:40 ET | 300 | 7.38 |
| 11:42 ET | 100 | 7.385 |
| 11:44 ET | 235 | 7.38 |
| 11:45 ET | 200 | 7.4 |
| 12:00 ET | 100 | 7.4 |
| 12:02 ET | 100 | 7.4 |
| 12:05 ET | 200 | 7.41 |
| 12:07 ET | 535 | 7.4 |
| 12:25 ET | 100 | 7.4 |
| 12:32 ET | 100 | 7.4 |
| 12:36 ET | 600 | 7.41 |
| 12:39 ET | 100 | 7.42 |
| 12:54 ET | 100 | 7.42 |
| 12:56 ET | 219 | 7.42 |
| 01:01 ET | 400 | 7.43 |
| 01:03 ET | 850 | 7.42 |
| 01:06 ET | 100 | 7.43 |
| 01:12 ET | 100 | 7.43 |
| 01:17 ET | 116 | 7.4296 |
| 01:19 ET | 100 | 7.44 |
| 01:24 ET | 100 | 7.425 |
| 01:26 ET | 120 | 7.43 |
| 01:28 ET | 200 | 7.44 |
| 01:37 ET | 100 | 7.445 |
| 01:42 ET | 538 | 7.425 |
| 01:51 ET | 200 | 7.42 |
| 01:57 ET | 1044 | 7.43 |
| 02:04 ET | 100 | 7.42 |
| 02:09 ET | 841 | 7.41 |
| 02:11 ET | 300 | 7.4 |
| 02:13 ET | 257 | 7.39 |
| 02:18 ET | 113 | 7.3906 |
| 02:20 ET | 200 | 7.39 |
| 02:22 ET | 100 | 7.38 |
| 02:24 ET | 1179 | 7.36 |
| 02:26 ET | 300 | 7.36 |
| 02:33 ET | 100 | 7.35 |
| 02:38 ET | 200 | 7.35 |
| 02:40 ET | 100 | 7.36 |
| 02:45 ET | 202 | 7.34 |
| 02:47 ET | 100 | 7.36 |
| 02:49 ET | 700 | 7.36 |
| 02:51 ET | 300 | 7.36 |
| 02:56 ET | 476 | 7.35 |
| 03:00 ET | 3601 | 7.36 |
| 03:03 ET | 1132 | 7.36 |
| 03:09 ET | 100 | 7.36 |
| 03:14 ET | 600 | 7.35 |
| 03:16 ET | 100 | 7.35 |
| 03:18 ET | 200 | 7.36 |
| 03:20 ET | 937 | 7.34 |
| 03:21 ET | 150 | 7.3399 |
| 03:23 ET | 400 | 7.33 |
| 03:25 ET | 1562 | 7.29 |
| 03:27 ET | 100 | 7.31 |
| 03:36 ET | 200 | 7.31 |
| 03:38 ET | 1775 | 7.3 |
| 03:39 ET | 100 | 7.3 |
| 03:43 ET | 100 | 7.3 |
| 03:45 ET | 200 | 7.3 |
| 03:48 ET | 1907 | 7.291 |
| 03:50 ET | 933 | 7.3 |
| 03:52 ET | 1000 | 7.31 |
| 03:54 ET | 1305 | 7.3 |
| 03:56 ET | 1000 | 7.3 |
| 03:57 ET | 493 | 7.3 |
| 03:59 ET | 31002 | 7.28 |
Apr 10, 2024
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024, from 4:05PM ET on Wednesday Apr 10, 2024 by Dow Jones
4:05PM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 3, 2024
DJ Pulmonx Price Target Maintained With a $17.00/Share by Piper Sandler, from 12:15PM ET on Wednesday Apr 03, 2024 by Dow Jones
12:15PM ET on Wednesday Apr 03, 2024 by Dow Jones
Apr 2, 2024
DJ Pulmonx Taps Mehul Joshi as Finance Chief, from 4:58PM ET on Tuesday Apr 02, 2024 by Dow Jones
4:58PM ET on Tuesday Apr 02, 2024 by Dow JonesPulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer, from 4:05PM ET on Tuesday Apr 02, 2024 by Dow Jones
4:05PM ET on Tuesday Apr 02, 2024 by Dow JonesPress Release: Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer, from 4:05PM ET on Tuesday Apr 02, 2024 by Dow Jones
4:05PM ET on Tuesday Apr 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pulmonx Corp | 282.6M | -4.5x | --- |
Sight Sciences Inc | 261.6M | -4.6x | --- |
CVRx Inc | 317.2M | -7.4x | --- |
Utah Medical Products Inc | 236.6M | 14.4x | +2.27% |
Semler Scientific Inc | 183.6M | 9.9x | +31.99% |
Senseonics Holdings Inc | 220.7M | -4.1x | --- |
Company Information
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients. The StratX Platform is a cloud-based quantitative CT analysis service that offers physicians with a report that is designed for its solution, which includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation and has been validated in multiple randomized controlled clinical trials.
Contact Information
- Headquarters
- 700 Chesapeake DrREDWOOD CITY, CA, United States 94063
- Phone
- 650-934-2600
- Fax
- 302-655-5049
Executives
- Independent Chairman of Board
- Dana Mead
- President, Chief Executive Officer, Director
- Steven Williamson
- Chief Financial Officer and Principal Financial and Chief Accounting Officer
- Mehul Joshi
- General Counsel
- David Lehman
- Chief Commercial Officer
- Geoffrey Rose
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $282.6M |
|---|---|
Revenue (TTM) | $68.7M |
Shares Outstanding | 38.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.67 |
EPS | $-1.60 |
Book Value | $3.07 |
P/E Ratio | -4.5x |
Price/Sales (TTM) | 4.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -90.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
